Search results
Analyst Report: Bristol-Myers Squibb Company
Morningstar Research via Yahoo Finance· 11 hours agoBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where ...
Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
Simply Wall St. via Yahoo Finance· 21 hours agoWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to...
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology...
Morningstar· 23 hours agoBristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income...
Morningstar· 2 days agoBristol Myers Squibb (NYSE: BMY) today announced ASPIRE (Accessibility, Sustainability, Patient-centric, Impact, Responsibility and Equity), a 10-year strategy to advance access to our innovative ...
Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 6 days agoKey Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price...
Bristol-Myers Squibb Co. [BMY] Records 50-Day SMA of $48.20 – Knox Daily
Knox Daily· 1 day agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Bristol-Myers Squibb Co. shares valued at $99,560 were purchased by BOERNER CHRISTOPHER ...
Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity - Bristol-Myers Squibb...
Benzinga· 3 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb . Looking at options history for Bristol-Myers Squibb BMY we detected ...
A Guide To The Risks Of Investing In Bristol-Myers Squibb Co.
Knox Daily· 4 days agoBristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal valued at $49.78 ...
Bristol Myers, Sanofi Liability in Hawaii Plavix Case Grows to $916 Million
Insurance Journal· 1 day agoA judge in Hawaii on Tuesday ordered Bristol Myers Squibb and Sanofi to pay more than $916 million...
This Unpopular Dividend Stock Is a Buy
The Motley Fool via AOL· 23 hours agoDividend stocks are an important anchor for well-balanced portfolios. Regular cash distributions can buffer a portfolio against market volatility and...
